Demo Data from EDBT 2026 / reviewers in the wild / expert
Dai Wu
dblp:199/4126
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2026
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Medical and health informatics · 50% Bioinformatics and computational biology · 50% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Medical and health informatics
clinical genomics |
1.0 | 1 | 2026 | Enhancing interpretation of clinical disease-associated copy number variations from multiple sequencing strategies with CNVSeeker · Bioinform. 2026 |
Bioinformatics and computational biology › cancer genomics › copy number analysis
copy number variation detection |
1.0 | 1 | 2026 | Enhancing interpretation of clinical disease-associated copy number variations from multiple sequencing strategies with CNVSeeker · Bioinform. 2026 |
Methods — techniques the papers use, named apart from their topics
variant classification · 1.0short-read sequencing · 1.0long-read sequencing · 1.0
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2026 | Enhancing interpretation of clinical disease-associated copy number variations from multiple sequencing strategies with CNVSeekerabstractMOTIVATION: DNA copy number variations (CNVs) exert a profound impact on major genetic disorders in humans. Although multiple sequencing technologies have become the first line of molecular diagnosis for CNVs, existing tools are unable to resolve the pathogenicity of CNVs directly from raw sequencing data. RESULTS: We developed CNVSeeker, a one-stop and easy-to-use pipeline that provides comprehensive analysis from raw sequencing data to variant interpretation reports, and supports multiple types of sequencing data including short-read data such as whole genome sequencing data and whole exome sequencing data, and long-read sequencing data from Pacific Biosciences HiFi platform or Oxford Nanopore Technologies platform. Through extensive benchmarking, CNVSeeker demonstrated comparable enhancement over the state-of-the-art methods for CNV calling. Moreover, CNVSeeker enables significantly precise variant classification with an accuracy of ∼87%. By applying CNVSeeker to 1946 individuals with autism spectrum disorder (ASD), a total of 133 ASD-associated CNVs in 122 patients were identified, yielding a diagnostic yield of ∼6.3%. Additionally, we have also provided a user-friendly webserver for intuitive visualization of results. This study highlights the potential of CNVSeeker to benefit clinicians and geneticists with limited bioinformatic skill by aiding them interpret CNVs directly from various types of raw sequencing data for auxiliary disease diagnosis. AVAILABILITY AND IMPLEMENTATION: The web server is freely available at https://genemed.tech/cnvseeker and the open-source code can be found at https://github.com/lovelycatZ/CNVSeeker. Xudong Xiang, Xinxin Mao, Tengfei Luo, Chenbin Liu, Bozhao Li, Pei Yu, Dai Wu, Yixiao Zhu, Guihu Zhao, Jinchen Li |
Bioinform. | 8 |